EUVIMEDEUVIMED entdecken
Crossref

“PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene

Can Yurttas, Susanne Berchtold, Nisar Malek, Michael Bitzer, Ulrich M. Lauer

Human Gene Therapy Clinical Development · 2014

DOI: 10.1089/hum.2013.127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2014. Verfasst von Can Yurttas und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yurttas, C., Berchtold, S., Malek, N., Bitzer, M., & Lauer, U. M. (2014). “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2013.127

Vancouver

Yurttas C, Berchtold S, Malek N, Bitzer M, Lauer UM. “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Human Gene Therapy Clinical Development. 2014. doi:10.1089/hum.2013.127

BibTeX
@article{Yurttas2014,
  author = {Yurttas, Can and Berchtold, Susanne and Malek, Nisar and Bitzer, Michael and Lauer, Ulrich M.},
  title = {“PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene},
  journal = {Human Gene Therapy Clinical Development},
  year = {2014},
  doi = {10.1089/hum.2013.127}
}
Kostenlos starten →